Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norcross

Showing results (461-470 of 483) with videos related to

Pageof 49
Sort By:
Heart Rhythm|December 8, 2024
Bleeding, stroke, and mortality risk of patients with septic shock receiving anticoagulation for atrial fibrillationSahitya Allam, Jonathan Na, Joanne Moon, et al.
Journal of Medicinal Chemistry|December 21, 2013
Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasisHari Babu Tatipaka, J Robert Gillespie, Arnab K Chatterjee, et al.
Molecular Psychiatry|May 30, 2012
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weightF G Revel, J-L Moreau, B Pouzet, et al.
Frontiers in Immunology|February 26, 2021
Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated PeptidesMontserrat Puig, Suryatheja Ananthula, Ramesh Venna, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2011
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activityFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 16, 2010
Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitabilityKhyobeni Mozhui, Rose-Marie Karlsson, Thomas L Kash, et al.
Npj Antimicrobials and Resistance|January 22, 2025
Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniquesHazem F M Abdelaal, Bryan J Berube, Brendan K Podell, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2008
CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3'-fluoro-4'-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1'-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonistCuyue Tang, Brian A Carr, Frédéric Poignant, et al.
Biological Psychiatry|June 19, 2012
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeuticsFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
Journal of Medicinal Chemistry|December 14, 2011
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitorsStephen Brand, Laura A T Cleghorn, Stuart P McElroy, et al.
Pageof 49

Showing results (461-470 of 483) with videos related to

Sort By:
Pageof 49
Heart Rhythm|December 8, 2024
Bleeding, stroke, and mortality risk of patients with septic shock receiving anticoagulation for atrial fibrillationSahitya Allam, Jonathan Na, Joanne Moon, et al.
Journal of Medicinal Chemistry|December 21, 2013
Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasisHari Babu Tatipaka, J Robert Gillespie, Arnab K Chatterjee, et al.
Molecular Psychiatry|May 30, 2012
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weightF G Revel, J-L Moreau, B Pouzet, et al.
Frontiers in Immunology|February 26, 2021
Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated PeptidesMontserrat Puig, Suryatheja Ananthula, Ramesh Venna, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2011
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activityFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 16, 2010
Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitabilityKhyobeni Mozhui, Rose-Marie Karlsson, Thomas L Kash, et al.
Npj Antimicrobials and Resistance|January 22, 2025
Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniquesHazem F M Abdelaal, Bryan J Berube, Brendan K Podell, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2008
CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3'-fluoro-4'-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1'-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonistCuyue Tang, Brian A Carr, Frédéric Poignant, et al.
Biological Psychiatry|June 19, 2012
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeuticsFlorent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, et al.
Journal of Medicinal Chemistry|December 14, 2011
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitorsStephen Brand, Laura A T Cleghorn, Stuart P McElroy, et al.
Pageof 49